Hello, Guest
Login
Sign Up
 
 

Big Income on Wednesday: STZ, CBK, OPK, HPTX

PennyStocksUpdate.biz is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.

 
 
Repost This

New York, NY -- (SBWIRE) -- 01/16/2013 -- Constellation Brands Inc (NYSE:STZ) soared 3.06% and closed at $36.41 on a traded volume of 3.54 million shares. The Company said that Eric Morham, president of the Company’s Canadian business will retire effective May 31, 2013 after 40 years in the beverage alcohol industry.Stifel Nicolaus increased the price target on the stock from $42.00 to $45.00 in a research note. The firm currently has a buy rating on the stock.

Can STZ Continue To Move Higher? Find Out Here

Christopher & Banks Corporation (NYSE:CBK) 8% HIGHER; expects to report a comparable store sales increase in the high teens for the fourth fiscal quarter as compared to the Company's previous guidance of a comparable store sales increase in the high single to low double digits. The Company also announced that it expects cash and cash equivalents at the end of the fourth fiscal quarter (February 2, 2013) to be in the range of $37 million to $38 million.

Can CBK Continue To Move Higher? Find Out Here

Opko Health Inc. (NYSE:OPK) opened at $5.32 and oscillated in the range of $5.30 and $5.78 in its latest trading session. It closed at $5.71, up 6.13 percent from its previous close of $5.38. Opko Health shows bullish trend and the stock’s first resistance level is at $5.85. On the downside, it may slip to $5.19. Opko Health garnered good insider interest as its CEO recently bought 46,000 shares. The company also augmented its pact with Bristol Myers Squibb. It also signed a new deal to acquire Cytochroma, a Canadian drug firm. Opko Health is expected to pay $100 million for the deal.

Find out more on OPK by getting the free full report here

Hyperion Therapeu (NASDAQ:HPTX) is very active today and traded between $11.51 - 14.30 with total traded volume of 237463 shares. At a current price of 14.00, HPTX is +2.00 - +16.67% from the previous close of $12.00. Moreover, At Current Market Price, HPTX is in the distance of +29.25% from its 50-day Moving Average price of $10.8315 and +31.67% from its 200-day Moving Average price of $10.6323.

How Should Investors Trade HPTX After The Recent Volatile Moves? Find Out Here

DISCLAIMER
Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..

Contact:
PennyStocksUpdate.biz
info@pennystocksupdate.biz